The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Twigg, Matthew S ^a,b   Brockbank, Simon ^b   Lowry, Philip ^b   Fitzgerald, S Peter ^b   Taggart, Clifford ^a   Weldon, Sinéad ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Randox Laboratories Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CATHEPSIN G; ELAFIN; LEUKOCYTE ELASTASE; MYELOBLASTIN; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SYNTHETIC SERINE PROTEASE INHIBITOR; UNCLASSIFIED DRUG; SLPI PROTEIN, HUMAN; TIPRELESTAT;

ARTICLE; CYSTIC FIBROSIS; CYSTIC FIBROSIS LUNG DISEASE; ENZYME ACTIVITY; HUMAN; LUNG DISEASE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FAMILY; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ALPHA 1-ANTITRYPSIN; CATHEPSIN G; CYSTIC FIBROSIS; ELAFIN; HUMANS; LEUKOCYTE ELASTASE; MYELOBLASTIN; NEUTROPHILS; PROTEASE INHIBITORS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEASES;

EID: 84936792006     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/293053     Document Type: Article

References (123)

1. G. J. Gibson, R. Loddenkemper, B. Lundback, and Y. Sibille, "Respiratory health and disease in Europe: the new European LungWhite Book" European Respiratory Journal, vol. 42, no. 3, pp. 559-563, 2013.
2. B. C. Tilly, M. C. Winter, L. S. Ostedgaard, C. O'Riordan, A. E. Smith, and M. J. Welsh, "Cyclic AMP-dependent protein kinase activation of cystic fibrosis transmembrane conductance regulator chloride channels in planar lipid bilayers" The Journal of Biological Chemistry, vol. 267, no. 14, pp. 9470-9473, 1992.
3. T. S. Murray, M. Egan, and B. I. Kazmierczak, "Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients" Current Opinion in Pediatrics, vol. 19, no. 1, pp. 83-88, 2007.
4. N. Pillarisetti, E. Williamson, B. Linnane et al., "Infection, inflammation, and lung function decline in infants with cystic fibrosis" American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 1, pp. 75-81, 2011.
5. A. P. Watt, J. Courtney, J. Moore, M. Ennis, and J. S. Elborn, "Neutrophil cell death, activation and bacterial infection in cystic fibrosis" Thorax, vol. 60, no. 8, pp. 659-664, 2005.
6. D. Kube, U. Sontich, D. Fletcher, and P. B. Davis, "Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines" The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 280, no. 3, pp. L493-L502, 2001.
7. P. Greally, M. J. Hussein, A. J. Cook, A. P. Sampson, P. J. Piper, and J. F. Price, "Sputum tumour necrosis factor-And leukotriene concentrations in cystic fibrosis" Archives ofDisease in Childhood, vol. 68, no. 3, pp. 389-392, 1993.
8. D. G. Downey, S.C. Bell, and J. S. Elborn, "Neutrophils in cystic fibrosis" Thorax, vol. 64, no. 1, pp. 81-88, 2009.
9. E. Kelly, C. M. Greene, and N. G. McElvaney, "Targeting neutrophil elastase in cystic fibrosis"ExpertOpinion onTherapeutic Targets, vol. 12, no. 2, pp. 145-157, 2008.
10. M. Conese, E. Copreni, S. di Gioia, P. de Rinaldis, and R. Fumarulo, "Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease" Journal of Cystic Fibrosis, vol. 2, no. 3, pp. 129-135, 2003.
11. E. Hayes, K. Pohl, N.G. McElvaney, and E. P. Reeves, "Thecystic fibrosis neutrophil: a specialized yet potentially defective cell" Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 2, pp. 97-112, 2011.
12. T. S. Cohen and A. Prince, "Cystic fibrosis: a mucosal immunodeficiency syndrome" Nature Medicine, vol. 18, no. 4, pp. 509-519, 2012.
13. A. M. Gifford and J. D. Chalmers, "The role of neutrophils in cystic fibrosis" Current Opinion in Hematology, vol. 21, no. 1, pp. 16-22, 2014.
14. C. Haslett, "Granulocyte apoptosis and its role in the resolution and control of lung inflammation" The American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, pp. S5-S11, 1999.
15. B. Korkmaz, M. S. Horwitz, D. E. Jenne, and F. Gauthier, "Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases" Pharmacological Reviews, vol. 62, no. 4, pp. 726-759, 2010.
16. C. Lopez-Ot and J. S. Bond, "Proteases: multifunctional enzymes in life and disease" Journal of Biological Chemistry, vol. 283, no. 45, pp. 30433-30437, 2008.
17. B. Korkmaz, T. Moreau, and F. Gauthier, "Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions" Biochimie, vol. 90, no. 2, pp. 227-242, 2008.
18. C. T. N. Pham and T. J. Ley, "Dipeptidyl peptidase I is required for the processing and activation of granzymesAand B in vivo" Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8627-8632, 1999.
19. P. J. Wolters, C. T. N. Pham, D. J. Muilenburg, T. J. Ley, and G. H. Caughey, "Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice" The Journal of Biological Chemistry, vol. 276, no. 21, pp. 18551-18556, 2001.
20. A. M. Adkison, S. Z. Raptis, D. G. Kelley, and C. T. N. Pham, "Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis"The Journal of Clinical Investigation, vol. 109, no. 3, pp. 363-371, 2002.
21. S. Skld, L. Zeberg, U. Gullberg, and T. Olofsson, "Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis" Experimental Hematology, vol. 30, no. 7, pp. 689-696, 2002.
22. U. Gullberg, A. Lindmark, G. Lindgren, A.-M. Persson, E. Nilsson, and I. Olsson, "Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL" The Journal of Biological Chemistry, vol. 270, no. 21, pp. 12912-12918, 1995.
23. V. Witko-Sarsat, L. Halbwachs-Mecarelli, A. Schuster et al., "Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum" American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 4, pp. 729-736, 1999.
24. R. Sepper, Y. T. Konttinen, T. Ingman, and T. Sorsa, "Presence, activities, and molecular forms of cathepsin G, elastase, 1-Antitrypsin, and 1-Antichymotrypsin in bronchiectasis" Journal of Clinical Immunology, vol. 15, no. 1, pp. 27-34, 1995.
25. M. Zimmer, R. L. Medcalf, T. M. Fink, C. Mattmann, P. Lichter, and D. E. Jenne, "Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter" Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 8215-8219, 1992.
26. M. W. Konstan, K. A. Hilliard, T. M. Norvell, and M. Berger, "Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation"AmericanJournal of Respiratory andCritical Care Medicine, vol. 150, no. 2, pp. 448-454, 1994.
27. D. Y. Koller, R. Urbanek, and M. Gtz, "Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis"The American Journal of Respiratory and Critical CareMedicine, vol. 152, no. 2, pp. 629-633, 1995.
28. C. Taggart, R. J. Coakley, P. Greally, G. Canny, S. J. O'Neill, and N. G. McElvaney, "Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-Alpha and interleukin-8" The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 1, pp. L33-L41, 2000.
29. K. Pohl, E. Hayes, J. Keenanet al., "Aneutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy" Blood, vol. 124, no. 7, pp. 999-1009, 2014.
30. J. A. Voynow, B. M. Fischer, and S. Zheng, "Proteases and cystic fibrosis"The International Journal of Biochemistry & Cell Biology, vol. 40, no. 6-7, pp. 1238-1245, 2008.
31. S. M. Kreda, C. W. Davis, and M. C. Rose, "CFTR, mucins, and mucus obstruction in cystic fibrosis" Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 9, Article ID a009589, 2012.
32. J. A. Voynow and B. K. Rubin, "Mucins, mucus, and sputum" Chest, vol. 135, no. 2, pp. 505-512, 2009.
33. M. X. G. Shao and J. A. Nadel, "Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-converting enzyme" The Journal of Immunology, vol. 175, no. 6, pp. 4009-4016, 2005.
34. J.-S. Song, K.-S. Cho, H.-K. Yoon, H.-S. Moon, and S.-H. Park, "Neutrophil elastase causesMUC5ACmucin synthesis via EGF receptor, ERK and NF-B pathways in A549 cells" Korean Journal of Internal Medicine, vol. 20, no. 4, pp. 275-283, 2005.
35. B. M. Fischer and J. A. Voynow, "Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species" The American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 4, pp. 447-452, 2002.
36. B. M. Fischer, J. G. Cuellar, M. L. Diehl et al., "Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells" American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 284, no. 4, pp. L671-L679, 2003.
37. I. Kuwahara, E. P. Lillehoj, A. Hisatsune et al., "Neutrophil elastase stimulates MUC1 gene expression through increased Sp1 binding to the MUC1 promoter" American Journal of Physiology: Lung Cellular andMolecular Physiology, vol. 289, no. 2, pp. L355-L362, 2005.
38. I. Kuwahara, E. P. Lillehoj, T. Koga, Y. Isohama, T. Miyata, and K. C. Kim, "The signaling pathway involved in neutrophil elastase-stimulated MUC1 transcription" American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 6, pp. 691-698, 2007.
39. J.-A. Park, F. He, L. D. Martin, Y. Li, B. N. Chorley, and K. B. Adler, "Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinaseC-mediatedmechanism" The American Journal of Pathology, vol. 167, no. 3, pp. 651-661, 2005.
40. S. Gehrig, J. Duerr, M. Weitnauer et al., "Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosislike lung disease" American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 9, pp. 1082-1092, 2014.
41. R. Amitani, R. Wilson, A. Rutman et al., "Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium"American Journal of Respiratory Cell and Molecular Biology, vol. 4, no. 1, pp. 26-32, 1991.
42. M. A. Mall, "Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models" Journal of AerosolMedicine and Pulmonary Drug Delivery, vol. 21, no. 1, pp. 13-24, 2008.
43. A. B. Astrand, M. Hemmerling, J. Root et al., "Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition" The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 308, no. 1, pp. L22-L32, 2015.
44. G. Dring, "The role of neutrophil elastase in chronic inflammation" American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 6, pp. S114-S117, 1994.
45. H. Nakamura, K. Yoshimura, N. G. McElvaney, and R. G. Crystal, "Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line" Journal of Clinical Investigation, vol. 89, no. 5, pp. 1478-1484, 1992.
46. J. M. Devaney, C.M. Greene, C. C. Taggart, T. P. Carroll, S. J. O'Neill, andN. G. McElvaney, "Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4" FEBS Letters, vol. 544, no. 1-3, pp. 129-132, 2003.
47. C. Taggart, D. Cervantes-Laurean, G. Kim et al., "Oxidation of either methionine 351 or methionine 358 in alpha1-Antitrypsin causes loss of anti-neutrophil elastase activity" The Journal of Biological Chemistry, vol. 275, no. 35, pp. 27258-27265, 2000.
48. D. E. Walsh, C. M. Greene, T. P. Carroll et al., "Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/ IRAK/TRAF-6 in human bronchial epithelium" Journal of Biological Chemistry, vol. 276, no. 38, pp. 35494-35499, 2001.
49. E. A. Kurt-Jones, L. Mandell, C. Whitney et al., "Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils" Blood, vol. 100, no. 5, pp. 1860-1868, 2002.
50. G. Ferry, M. Lonchampt, L. Pennel, G. de Nanteuil, E. Canet, and G. C. Tucker, "Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury" FEBS Letters, vol. 402, no. 2-3, pp. 111-115, 1997.
51. P. L. Jackson, X. Xu, L. Wilson et al., "Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction" Molecular Medicine, vol. 16, no. 5-6, pp. 159-166, 2010.
52. Y. S. Lopez-Boado, M. Espinola, S. Bahr, and A. Belaaouaj, "Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity" The Journal of Immunology, vol. 172, no. 1, pp. 509-515, 2004.
53. A. Sonawane, J. Jyot, R. During, and R. Ramphal, "Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa" Infection and Immunity, vol. 74, no. 12, pp. 6682-6689, 2006.
54. A. Prince, "Flagellar activation of epithelial signaling"American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 5, pp. 548-551, 2006.
55. M. F. Tosi, H. Zakem, and M. Berger, "Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch" Journal of Clinical Investigation, vol. 86, no. 1, pp. 300-308, 1990.
56. C.W. van den Berg, D. V. Tambourgi, H. W. Clark, S. J. Hoong, O. B. Spiller, and E. P. McGreal, "Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor"The Journal of Immunology, vol. 192, no. 4, pp. 1787-1795, 2014.
57. M. P. Rogan, C. C. Taggart, C. M. Greene, P. G. Murphy, S. J. O'Neill, and N. G. McElvaney, "Loss of microbial activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis" Journal of Infectious Diseases, vol. 190, no. 7, pp. 1245-1253, 2004.
58. S. Griffin, C. C. Taggart, C. M. Greene, S. O'Neill, and N. G. McElvaney, "Neutrophil elastase up-regulates human-defensin-2 expression in human bronchial epithelial cells" FEBS Letters, vol. 546, no. 2-3, pp. 233-236, 2003.
59. R. W. Vandivier, V. A. Fadok, P. R. Hoffmann et al., "Elastasemediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis" The Journal of Clinical Investigation, vol. 109, no. 5, pp. 661-670, 2002.
60. G. Doring, F. Frank, C. Boudier, S. Herbert, B. Fleischer, and G. Bellon, "Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis" Journal of Immunology, vol. 154, no. 9, pp. 4842-4850, 1995.
61. K. Le-Barillec, M. Si-Tahar, V. Balloy, and M. Chignard, "Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation" Journal of Clinical Investigation, vol. 103, no. 7, pp. 1039-1046, 1999.
62. T. A. Fuchs, U. Abed, C. Goosmann et al., "Novel cell death program leads to neutrophil extracellular traps" The Journal of Cell Biology, vol. 176, no. 2, pp. 231-241, 2007.
63. V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps" Journal of Cell Biology, vol. 191, no. 3, pp. 677-691, 2010.
64. K.D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, "A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis" Cell Reports, vol. 8, no. 3, pp. 883-896, 2014.
65. V. Brinkmann, U. Reichard, C. Goosmann et al., "Neutrophil extracellular traps kill bacteria" Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
66. J. V. Fahy and B. F. Dickey, "Medical progress: airway mucus function and dysfunction" The New England Journal of Medicine, vol. 363, no. 23, pp. 2233-2247, 2010.
67. A. V. Dubois, A. Gauthier, D. Brea et al., "Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum" American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 1, pp. 80-86, 2012.
68. A.V. Dubois, P. Midoux, D. Gras et al., "Poly-L-lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum" The American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 6, pp. 703-709, 2013.
69. A. B. Sturrock, R. Espinosa III, J. R. Hoidal, and M. M. Le Beau, "Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3" Cytogenetics and Cell Genetics, vol. 64, no. 1, pp. 33-34, 1993.
70. R. Goldschmeding, C. E. van der Schoot, D. ten Bokkel Huinink et al., "Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils" Journal of Clinical Investigation, vol. 84, no. 5, pp. 1577-1587, 1989.
71. P. E. van den Steen, P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker, "Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-And leaves RANTES and MCP-2 intact" Blood, vol. 96, no. 8, pp. 2673-2681, 2000.
72. V. Turk, V. Stoka, O. Vasiljeva et al., "Cysteine cathepsins: from structure, function and regulation to new frontiers" Biochimica et Biophysica Acta, vol. 1824, no. 1, pp. 68-88, 2012.
73. G. Salvesen and J. J. Enghild, "Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases" Biomedica Biochimica Acta, vol. 50, no. 4-6, pp. 665-671, 1991.
74. F. Rubio, J. Cooley, F. J. Accurso, and E. Remold-O'Donnell, "Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease" Thorax, vol. 59, no. 4, pp. 318-323, 2004.
75. S. Ranganathan, K. J. Simpson, D. C. Shaw, and K. R. Nicholas, "The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling" Journal of Molecular Graphics and Modelling, vol. 17, no. 2, pp. 106-113, 1999.
76. A. Clauss, H. Lilja, and A. Lundwall, "A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein" The Biochemical Journal, vol. 368, no. 1, pp. 233-242, 2002.
77. A. Scott, S. Weldon, and C. C. Taggart, "SLPI and elafin: multifunctional antiproteases of the WFDC family" Biochemical Society Transactions, vol. 39, no. 5, pp. 1437-1440, 2011.
78. U. Seemller, M. Arnhold, H. Fritz et al., "The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor" FEBS Letters, vol. 199, no. 1, pp. 43-48, 1986.
79. B. Bohm, T. Aigner, R. Kinne, and H. Burkhardt, "The serineprotease inhibitor of cartilage matrix is not a chondrocytic gene product" European Journal of Biochemistry, vol. 207, no. 2, pp. 773-779, 1992.
80. S. van Wetering, A. C. van der Linden, M. A. J. A. van Sterkenburg et al., "Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins"TheAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 1, pp. L51-L58, 2000.
81. F.-Y. Jin, C. Nathan, D. Radzioch, and A. Ding, "Secretory leukocyte protease inhibitor: amacrophage product induced by and antagonistic to bacterial lipopolysaccharide" Cell, vol. 88, no. 3, pp. 417-426, 1997.
82. W. Kammouni, C. Figarella, N. Baeza, S. Marchand, and M. D. Merten, "Pseudomonas aeruginosa lipopolysaccharide induces CF-like alteration of protein secretion by human tracheal gland cells" Biochemical and Biophysical Research Communications, vol. 241, no. 2, pp. 305-311, 1997.
83. H. Saitoh, T. Masuda, S. Shimura, T. Fushimi, and K. Shirato, "Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands" American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 280, no. 1, pp. L79-L87, 2001.
84. J. B. Vos, M. A. van Sterkenburg, K. F. Rabe, J. Schalkwijk, P. S. Hiemstra, and N. A. Datson, "Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of earlymediators of host defense" Physiological Genomics, vol. 21, no. 3, pp. 324-336, 2005.
85. S. P. Eisenberg, K. K. Hale, P. Heimdal, and R. C. Thompson, "Location of the protease-inhibitory region of secretory leukocyte protease inhibitor"The Journal of Biological Chemistry, vol. 265, no. 14, pp. 7976-7981, 1990.
86. C. C. Taggart, S.-A. Cryan, S. Weldon et al., "Secretory leucoprotease inhibitor binds to NF-B binding sites in monocytes and inhibits p65 binding"The Journal of ExperimentalMedicine, vol. 202, no. 12, pp. 1659-1668, 2005.
87. A. B. Lentsch, J. A. Jordan, B. J. Czermak et al., "Inhibition of NF-B activation and augmentation of IB by secretory leukocyte protease inhibitor during lung inflammation" The American Journal of Pathology, vol. 154, no. 1, pp. 239-247, 1999.
88. C. C. Taggart, C. M. Greene, N. G. McElvaney, and S. O'Neill, "Secretory leucoprotease inhibitor prevents lipopolysaccharideinduced IB degradationwithout affecting phosphorylation or ubiquitination"The Journal of Biological Chemistry, vol. 277, no. 37, pp. 33648-33653, 2002.
89. C. C. Taggart, G. J. Lowe, C. M. Greene et al., "Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor" Journal of Biological Chemistry, vol. 276, no. 36, pp. 33345-33352, 2001.
90. S. Weldon, P. McNally, N. G. McElvaney et al., "Decreased levels of secretory leucoprotease inhibitor in the Pseudomonasinfected cystic fibrosis lung are due to neutrophil elastase degradation" Journal of Immunology, vol. 183, no. 12, pp. 8148-8156, 2009.
91. J. M. Sallenave and A. Silva, "Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions" American Journal of Respiratory Cell and Molecular Biology, vol. 8, no. 4, pp. 439-445, 1993.
92. N. Guyot, M.-L. Zani, M.-C. Maurel, S. Dallet-Choisy, and T. Moreau, "Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase" Biochemistry, vol. 44, no. 47, pp. 15610-15618, 2005.
93. O. Wiedow, J. M. Schrder, H. Gregory, J. A. Young, and E. Christophers, "Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence" The Journal of Biological Chemistry, vol. 265, no. 25, pp. 14791-14795, 1990.
94. K. Nara, S. Ito, T. Ito et al., "Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminasemediated anchoring sequence termed 'cementoin'" Journal of Biochemistry, vol. 115, no. 3, pp. 441-448, 1994.
95. J.-M. Sallenave, "The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease" Respiratory Research, vol. 1, no. 2, pp. 87-92, 2000.
96. M.W. Butler, I. Robertson, C.M. Greene, S. J.O'Neill, C. C. Taggart, andN. G. McElvaney, "Elafin prevents lipopolysaccharideinduced AP-1 and NF-B activation via an effect on the ubiquitin-proteasome pathway"The Journal of Biological Chemistry, vol. 281, no. 46, pp. 34730-34735, 2006.
97. E. Vachon, Y. Bourbonnais, C. D. Bingle, S. J. Rowe, M. F. Janelle, and G. M. Tremblay, "Anti-inflammatory effect of preelafin in lipopolysaccharide-induced acute lung inflammation" Biological Chemistry, vol. 383, no. 7-8, pp. 1249-1256, 2002.
98. G. M. Tremblay, E. Vachon, C. Larouche, and Y. Bourbonnais, "Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2)" Chest, vol. 121, no. 2, pp. 582-588, 2002.
99. N. Guyot, M. W. Butler, P. McNally et al., "Elafin, an elastasespecific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis" The Journal of Biological Chemistry, vol. 283, no.47, pp. 32377-32385, 2008.
100. N. Guyot, G. Bergsson, M.W. Butler et al., "Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases" Biological Chemistry, vol. 391, no. 6, pp. 705-716, 2010.
101. D. M. Small, M. L. Zani, D. J. Quinn et al., "A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation"MolecularTherapy, vol. 23, no. 1, pp. 24-31, 2014.
102. P. S. Hiemstra, R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman, "Antibacterial activity of antileukoprotease" Infection and Immunity, vol. 64, no. 11, pp. 4520-4524, 1996.
103. A. J. Simpson, A. I. Maxwell, J. R. W. Govan, C. Haslett, and J.-M. Sallenave, "Elafin (elastase-specific inhibitor) has antimicrobial activity against Gram-positive and Gram-negative respiratory pathogens" FEBS Letters, vol. 452, no. 3, pp. 309-313, 1999.
104. A. Bellemare, N. Vernoux, S. Morin, S.M. Gagn, and Y. Bourbonnais, "Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa" BMC Microbiology, vol. 10, article 253, 2010.
105. M. J. Banda, E. J. Clark, and Z. Werb, "Limited proteolysis by macrophage elastase inactivates human 1-proteinase inhibitor"The Journal of Experimental Medicine, vol. 152, no. 6, pp. 1563-1570, 1980.
106. M. J. Banda, A. G. Rice, G. L. Griffin, and R. M. Senior, "1-Proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase" Journal of Biological Chemistry, vol. 263, no. 9, pp. 4481-4484, 1988.
107. A. Churg, X. Wang, R.D. Wang, S. C. Meixner, E. L. G. Pryzdial, and J. L. Wright, "1-Antitrypsin suppresses TNF-And MMP-12 production by cigarette smoke-stimulated macrophages" American Journal of Respiratory Cell andMolecular Biology, vol. 37, no. 2, pp. 144-151, 2007.
108. J. A. Kramps, A. H. T. Te Boekhorst, J. A. M. Fransen, L. A. Ginsel, and J. H. Dijkman, "Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung: an immunoelectron microscopic study" The American Review of Respiratory Disease, vol. 140, no. 2, pp. 471-476, 1989.
109. J.-F. Mornex, A. Chytil-Weir, Y. Martinet, M. Courtney, J. P. LeCocq, and R. G. Crystal, "Expression of the alpha-1-Antitrypsin gene in mononuclear phagocytes of normal and alpha-1-Antitrypsin-deficient individuals" The Journal of Clinical Investigation, vol. 77, no. 6, pp. 1952-1961, 1986.
110. R. M. du Bois, J.-F. Bernaudin, P. Paakko et al., "Human neutrophils express the 1-Antitrypsin gene and produce 1-Antitrypsin" Blood, vol. 77, no. 12, pp. 2724-2730, 1991.
111. S. L. Martin, D. Downey, D. Bilton, M. T. Keogan, J. Edgar, and J. S. Elborn, "Safety and efficacy of recombinant alpha1-Antitrypsin therapy in cystic fibrosis" Pediatric Pulmonology, vol. 41, no. 2, pp. 177-183, 2006.
112. M. Griese, P. Latzin, M. Kappler et al., "Alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients" The European Respiratory Journal, vol. 29, no. 2, pp. 240-250, 2007.
113. F. Galli, A. Battistoni, R. Gambari et al., "Oxidative stress and antioxidant therapy in cystic fibrosis" Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1822, no. 5, pp. 690-713, 2012.
114. J. Michaelis, M. C. Vissers, and C. C. Winterbourn, "Human neutrophil collagenase cleaves alpha 1-Antitrypsin" The Biochemical Journal, vol. 270, no. 3, pp. 809-814, 1990.
115. Z. Zhang, P. G. Winyard, K. Chidwick et al., "Proteolysis of human native and oxidised alpha1-proteinase inhibitor by matrulysin and stromelysin" Biochimica et Biophysica Acta, vol. 1199, no. 2, pp. 224-228, 1994.
116. B. L. Roberts, W. Markland, K. Siranosian, M. J. Saxena, S. K. Guterman, and R. C. Ladner, "Protease inhibitor display M13 phage: selection of high-Affinity neutrophil elastase inhibitors" Gene, vol. 121, no. 1, pp. 9-15, 1992.
117. C. Delacourt, S. Herigault, C. Delclaux et al., "Protectionagainst acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor" American Journal of Respiratory Cell andMolecular Biology, vol. 26, no. 3, pp. 290-297, 2002.
118. F. K. Dunlevy, S. L. Martin, F. de Courcey, J. S. Elborn, and M. Ennis, "Anti-inflammatory effects of DX-890, a human neutrophil elastase inhibitor" Journal of Cystic Fibrosis, vol. 11, no. 4, pp. 300-304, 2012.
119. S. Attucci, A. Gauthier, B. Korkmaz et al., "EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis" Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 2, pp. 803-809, 2006.
120. T. Stevens, K. Ekholm, M. Granse et al., "AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase" The Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 1, pp. 313-320, 2011.
121. R. Stockley, A. De Soyza, K. Gunawardena et al., "Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis" Respiratory Medicine, vol. 107, no. 4, pp. 524-533, 2013.
122. C. Vogelmeier, T. O. Aquino, C. D. O'Brien, J. Perrett, and K. A. Gunawardena, "A randomised, placebo-controlled, dosefinding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium" COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 9, no. 2, pp. 111-120, 2012.
123. J. S. Elborn, J. Perrett, K. Forsman-Semb, J. Marks-Konczalik, K. Gunawardena, and N. Entwistle, "Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis" European Respiratory Journal, vol. 40, no. 4, pp. 969-976, 2012.